Trinomia 100 mg/40 mg/5 mg hard capsules
Authorisation PA1744/002/005 · Ferrer Internacional, S.A
- Licence holder
- Ferrer Internacional, S.A (all products →)
- Active substances
- Acetylsalicylic acid, Ramipril, Atorvastatin calcium trihydrate
- Clinical trials
- 13 clinical trials → 7 clinical trials → 47 clinical trials →
- Dosage form
- Capsule, hard
- Route of administration
- Oral use
- ATC codes
- C10BX, C10BX06
- First authorised
- 30/06/2017
- Prescription status
- Product subject to prescription which may be renewed (B)
- Supply
- Supply through pharmacies only
- Legal basis
- Fixed combination application (Article 10b of Directive No 2001/83/EC)
Acetylsalicylic acid: supply and approvals
21 authorised products on the HPRA list contain Acetylsalicylic acid. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 19 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 19 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 19 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
Ramipril: supply and approvals
32 authorised products on the HPRA list contain Ramipril. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 19 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 19 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 19 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
Atorvastatin calcium trihydrate: supply and approvals
111 authorised products on the HPRA list contain Atorvastatin calcium trihydrate. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 19 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 19 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 19 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 9 years (since 30 June 2017). The HPRA list marks it as marketed in Ireland.
Other medicines with Acetylsalicylic acid in Ireland
20 other products on the HPRA list contain Acetylsalicylic acid, from 11 licence holders; 12 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Aspirin Krka 75 mg gastro-resistant tablets | KRKA, d.d., Novo mesto | National authorisation (PA) | Marketed |
| Caprin 75 mg gastro-resistant tablets | Pinewood Laboratories Limited | National authorisation (PA) | Marketed |
| Disprin Direct 300 mg Orodispersible Tablets | Reckitt Benckiser Ireland Limited | National authorisation (PA) | Marketed |
| Disprin Extra Strength 500 mg Effervescent tablets | Reckitt Benckiser Ireland Limited | National authorisation (PA) | Marketed |
| Disprin Original 300 mg Dispersible Tablets | Reckitt Benckiser Ireland Limited | National authorisation (PA) | Marketed |
| Excedrin 250 mg/ 250 mg/ 65 mg film coated tablets | Haleon Ireland Limited | National authorisation (PA) | Marketed |
| Nu-seals 75 mg gastro-resistant tablets | Alliance Pharma (Ireland) Limited | National authorisation (PA) | Marketed |
| Trinomia 100 mg/20 mg/10 mg hard capsules | Ferrer Internacional, S.A | National authorisation (PA) | Marketed |
| Trinomia 100 mg/20 mg/2.5 mg hard capsules | Ferrer Internacional, S.A | National authorisation (PA) | Marketed |
| Trinomia 100 mg/20 mg/5 mg hard capsules | Ferrer Internacional, S.A | National authorisation (PA) | Marketed |
| Trinomia 100 mg/40 mg/10 mg hard capsules | Ferrer Internacional, S.A | National authorisation (PA) | Marketed |
| Trinomia 100 mg/40 mg/2.5 mg hard capsules | Ferrer Internacional, S.A | National authorisation (PA) | Marketed |
Other medicines with Ramipril in Ireland
31 other products on the HPRA list contain Ramipril, from 9 licence holders; 25 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Ramilo 1.25 mg tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| Ramilo 10 mg Tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| Ramilo 2.5 mg tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| Ramilo 5 mg tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| Ramipril Krka 1.25 mg tablets | KRKA, d.d., Novo mesto | National authorisation (PA) | Marketed |
| Ramipril Krka 10 mg tablets | KRKA, d.d., Novo mesto | National authorisation (PA) | Marketed |
| Ramipril Krka 2.5 mg tablets | KRKA, d.d., Novo mesto | National authorisation (PA) | Marketed |
| Ramipril Krka 5 mg tablets | KRKA, d.d., Novo mesto | National authorisation (PA) | Marketed |
| Ramipril Teva Pharma 1.25mg Tablets | Teva Pharma B.V. | National authorisation (PA) | Marketed |
| Ramipril Teva Pharma 10mg Tablets | Teva Pharma B.V. | National authorisation (PA) | Marketed |
| Ramipril Teva Pharma 2.5mg Tablets | Teva Pharma B.V. | National authorisation (PA) | Marketed |
| Ramipril Teva Pharma 5mg Tablets | Teva Pharma B.V. | National authorisation (PA) | Marketed |
Other substances in ATC group C10BX
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 6 other active substances share the group C10BX with this product:
Atorvastatin calcium (5) · Perindopril arginine (5) · Amlodipine besilate (5) · Amlodipine (1) · Valsartan (1) · Atorvastatin (1)
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
Ferrer Internacional, S.A holds 8 products on the HPRA list, with 5 different active substances; 6 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 20 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.